1st October 2021
Polaryx Therapeutics Receives FDA Orphan Drug Designation for PLX-200 for Treatment of Krabbe Disease
Krabbe Disease
Stay up to date
1st October 2021
Krabbe Disease
1st October 2021
GM2 Gangliosidosis
1st October 2021
GM2 Gangliosidosis
1st October 2021
GM1 Gangliosidosis
1st October 2021
Giant Axonal Neuropathy (GAN)
1st October 2021
Cockayne Syndrome (CS)
1st October 2021
Cerebral Autosomal Dominant Arteriopathy with Subcortical infarcts and Leukoencephalopathy (CADASIL)
1st October 2021
Adrenoleukodystrophy (ALD)
1st October 2021
Adrenoleukodystrophy (ALD)
1st October 2021
Adrenoleukodystrophy (ALD)
1st October 2021
Adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)/CSF1R related leukoencephalopathy
1st October 2021
Adrenoleukodystrophy (ALD)